Advent Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15,000
| Closed | -$3.26M | – | 238 |
|
|
2026
Q1 | $3.26M | Hold |
15,000
| – | – | 0.09% | 140 |
|
|
2025
Q4 | $3.43M | Buy |
+15,000
| New | +$3.42M | 0.07% | 157 |
|
|
2025
Q1 | – | Sell |
-18,000
| Closed | -$3.2M | – | 211 |
|
|
2024
Q4 | $3.2M | Buy |
+18,000
| New | +$3.31M | 0.07% | 128 |
|
|
2024
Q3 | – | Sell |
-30,000
| Closed | -$5.15M | – | 226 |
|
|
2024
Q2 | $5.15M | Buy |
30,000
+10,000
| +50% | +$1.66M | 0.12% | 107 |
|
|
2024
Q1 | $3.64M | Sell |
20,000
-10,000
| -33% | -$1.72M | 0.09% | 110 |
|
|
2023
Q4 | $4.65M | Buy |
30,000
+10,000
| +50% | +$1.46M | 0.11% | 122 |
|
|
2023
Q3 | $2.98M | Hold |
20,000
| – | – | 0.07% | 149 |
|
|
2023
Q2 | $2.69M | Hold |
20,000
| – | – | 0.05% | 172 |
|
|
2023
Q1 | $3.19M | Buy |
20,000
+5,000
| +33% | +$764K | 0.06% | 154 |
|
|
2022
Q4 | $2.42M | Buy |
+15,000
| New | +$2.3M | 0.04% | 189 |
|
|
2022
Q2 | – | Sell |
-37,000
| Closed | -$6M | – | 248 |
|
|
2022
Q1 | $6M | Sell |
37,000
-3,000
| -8% | -$436K | 0.1% | 163 |
|
|
2021
Q4 | $5.42M | Hold |
40,000
| – | – | 0.09% | 158 |
|
|
2021
Q3 | $4.32M | Buy |
40,000
+10,000
| +33% | +$1.14M | 0.08% | 150 |
|
|
2021
Q2 | $3.38M | Hold |
30,000
| – | – | 0.07% | 160 |
|
|
2021
Q1 | $3.25M | Buy |
+30,000
| New | +$3.21M | 0.07% | 142 |
|
|
2020
Q4 | – | Sell |
-40,000
| Closed | -$3.5M | – | 201 |
|
|
2020
Q3 | $3.5M | Buy |
40,000
+5,000
| +14% | +$471K | 0.08% | 132 |
|
|
2020
Q2 | $3.44M | Buy |
+35,000
| New | +$3.08M | 0.08% | 128 |
|
|
2018
Q2 | – | Sell |
-6,000
| Closed | -$568K | – | 278 |
|
|
2018
Q1 | $568K | Sell |
6,000
-33,243
| -85% | -$3.65M | 0.01% | 210 |
|
|
2017
Q4 | $3.79M | Buy |
39,243
+34,243
| +685% | +$3.23M | 0.07% | 151 |
|
|
2017
Q3 | $444K | Buy |
+5,000
| New | +$381K | 0.01% | 201 |
|
|
2015
Q4 | – | Sell |
-22,274
| Closed | -$1.21M | – | 466 |
|
|
2015
Q3 | $1.21M | Sell |
22,274
-4,926
| -18% | -$321K | 0.02% | 354 |
|
|
2015
Q2 | $1.83M | Buy |
27,200
+13,700
| +101% | +$894K | 0.03% | 350 |
|
|
2015
Q1 | $790K | Buy |
+13,500
| New | +$816K | 0.01% | 379 |
|
Other funds holding ABBV
Advent Capital Management's ABBV Position: Q2 2026 in Review
Advent Capital Management sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 15,000 shares — an estimated $3.26M sold.
Advent Capital Management first reported a position in ABBV in Q1 2015 and held it in 23 quarters. The position peaked at $6M in Q1 2022. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Advent Capital Management reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- Advent Capital Management sold 15,000 AbbVie shares in Q2 2026, an estimated $3.26M.
- Advent Capital Management first reported a position in AbbVie in Q1 2015 and held it in 23 quarters.
- Advent Capital Management's AbbVie position peaked at $6M in Q1 2022.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Advent Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.